Navigation Links
Regence BlueShield of Idaho Announces Executive Changes
Date:7/30/2009

BOISE, Idaho, July 30 /PRNewswire/ -- Regence, the largest nonprofit insurer in the Northwest/Intermountain Region, has named John Stellmon, president of Regence BlueShield of Idaho, to lead the company's Health Care Services division.

In his new expanded role, effective August 1, 2009, Stellmon will be responsible for executing the company's integrated health management programs. He will also oversee Pharmacy Services, Network Strategy and Performance and Health Care Services Planning and Performance Analytics. His primary office and residence will remain in Boise.

"Our Health Care Services division plays a vital role in leading and shaping the future of our company, and is a perfect fit for John's talents. His leadership in this critically important role will not only benefit Idaho - as it has for many years - but now the entire region," said Mark Ganz, President and CEO of Regence. "We must fundamentally rethink how insurers reimburse providers and incentivize integrated, high-quality, patient-centered care. Currently all insurers are falling short, and Regence is committed to advancing this change."

Stellmon, who has been with Regence for nearly 20 years, has held a variety of key positions within the company, including Chief Legal Counsel and Chief Operating Officer for Regence BlueShield of Idaho. He was named president in 2003, and has played a pivotal role in state and regional health care reform efforts. He is on the board for the Idaho Health Data Exchange, and in 2007 participated in Idaho Governor C.L. "Butch" Otter's two-day health care summit with legislators and health care representatives, a session designed to generate ideas for delivering affordable health care.

"The personal relationships that we share with physicians, hospitals and other health care providers, and our collaborative efforts to ensure quality care for our members, are
'/>"/>

SOURCE Regence
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Regence Wins Awards for Consumer Appeal to Transform Health Care
2. Eric Pettigrew to Lead Regences Community and Business Relations Efforts
3. Regence Wins Four Telly Awards for Health and Wellness Videos
4. Regence Launches Effort to Further Health Care Debate
5. Regence Adds New, Diverse Talent to Board of Directors
6. Regence Members in Oregon Can Now Access Provider Cost Information
7. American Imaging Management Launches Program with Regence
8. Regence Rate Assure(SM) Offers Employer Groups Guaranteed Rates, Benefits
9. Regence Optimistic About Health Industry Leaders Pledge to Cut Health Care Costs
10. Regence Foundation Grants $390,000 to Improve Health Care Safety Net
11. Regence Partners With KING5 to Provide Health and Wellness Information on Broadcasters Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... ROCHESTER, Minn. Positively charged gold nanoparticles are ... manage to avoid nanoparticle toxicity. Mayo Clinic researchers ... the nanoparticles effective against ovarian cancer cells. The ... of the Journal of Biological Chemistry ., ... ovarian cancer cells by preventing the cell death ...
(Date:5/21/2013)... Residents in St. Petersburg, FL have a ... Dr. David Sherberg, DMD, has joined Coast Dental Pasadena, ... provides preventive, restorative and cosmetic dentistry to patients age ... provide a wide variety of services including ... crowns, bridges, dentures, dental implant restorations, veneers, laser therapy, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 TheBeautyPlace.com helps ... day. TheBeautyPlace.com features a Big Day Kit including all ... might need to shine on their Wedding Day. , ... to smile about on their Wedding Day. Flowers blooming ... the start of wedding season. From Memorial Day to ...
(Date:5/21/2013)... St. Louis, MO (PRWEB) May 21, 2013 ... the first insulin pump she used with her patients in the ... the “big blue brick.” For the most part, it could only ... greatly in the 30 years since then, and the advantages are ... device worn on the outside of the body, often on a ...
(Date:5/21/2013)... The producers of Net Worth Business TV ... Ontario, Canada. The area is famous for its natural beauty ... It is located an hour from Toronto and is easily ... the Kawartha Hills, home to several towns, villages and hamlets ... area. Residents and visitors to this region will be able ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2
... Society, the largest non-government, not-for-profit funding source of cancer research ... training grants totaling more than $52.6 million in the first ... are new and 18 are renewals of previous grants. All ... The American Cancer Societys Research and Training Program has funded ...
... III development of ,GI-friendly, NSAIDs for mild ... Horizon Therapeutics, Inc. is pleased to announce that ... showcase Horizon,s ... including its recent completion of Series C financing, and ...
... Calcium Brand Enriches Consumer Care Division,s Key ... Nutritionals Product Portfolio, ... that its Consumer Care Division has received regulatory,approvals necessary to ... United States. The U.S. portion of the,transaction with Mission Pharmacal ...
... Oct. 5 Eli Lilly and Company,announced today ... the U.S. Food,and Drug Administration (FDA), the company ... fluoxetine HCl) U.S. product,labels. This new labeling information ... . The updates reflect recently completed pooled ...
... (CTI),(Nasdaq: CTIC ; MTAX) management will present at ... The conference will be held October 9-11, 2007, at ... Wednesday, October 10 at 12:45 p.m.,(PT). The conference will ... the presentation. The webcast can be accessed at, http://www.cticseattle.com ...
... SAN FRANCISCO, Calif., Oct. 5 Anesiva,Inc. (Nasdaq: ... company,s,chief executive officer, will present at the Biotechnology Industry,Organization,s ... am PDT in San Francisco. To access the ... http://www.anesiva.com and go to the Investors page, ...
Cached Medicine News:Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 2Health News:American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide 3Health News:Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting 2Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 2Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 2Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 4Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 5Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 6Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 7Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 8
(Date:5/21/2013)... WESTBURY, N.Y. , May 21, 2013  Vasomedical, Inc. ... specializing in the design, manufacture and sale of medical devices ... today that Dr. Jun Ma , President ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... study is to offer synopsis of the ...
(Date:5/21/2013)... Fla. , May 21, 2013  Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...
Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Conference on Monday, September 20, 2010.  The presentation is ... be accessed through the Company,s web site, www.regeneron.com ... of the presentation will be available after the live ...
... Shield Healthcare, a leading provider of medical supplies for ... annual story contest on "What Makes Caregiving Rewarding?" designed ... home healthcare  professionals, featuring celebrity contest judge, Sandra Mitchell ... caregiving is a demanding job. A significant number of ...
Cached Medicine Technology:Shield Healthcare Announces 10th Annual Caregiver Story Contest 2
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...
... The ImmunoDOT Autoimmunity Screening Panel 4 ... for screening and detection of autoantibodies ... (SS-A, SS-B, RNP/Sm, and Sm) in ... aid in the diagnosis of systemic ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
Rad-5 signal extraction pulse oximeter™...
Medicine Products: